Navigation Links
SynCardia's Record-Setting Q2 Marks 5th Consecutive Profitable Quarter
Date:8/9/2012

TUCSON, Ariz., Aug. 9, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart, announced today record-setting revenue for the quarter ended June 30, 2012, marking the company's best quarter to date and its fifth consecutive profitable quarter.

(Photo: http://photos.prnewswire.com/prnh/20120809/LA54747)

"Although many companies in the mechanical circulatory support space are struggling to be profitable, SynCardia has posted its best six months and trailing 12 months in company history for sales, implants and profits," said Michael Garippa, Chairman/CEO/President. "More implants of the SynCardia temporary Total Artificial Heart have been performed in the first half of 2012 than all 12 months of 2009. We are also in the final steps of submitting our Premarket Approval Supplement to the FDA for the Freedom® portable driver."

On April 24, 2012, SynCardia completed the minimum enrollment required by the FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom portable driver. Weighing 13.5 pounds, the Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. Worldwide, the Freedom driver, which is also CE approved for use in Europe, has supported more than 90 patients, accounting for more than 34 patient years of support.

In July, SynCardia announced that among the top 50 centers honored in U.S. News & World Report's "Best Hospitals" list for cardiology and heart surgery, 25 have added or are in the process of adding the SynCardia Total Artificial Heart to their programs. In April 2012, the number of hospitals that have completed or enrolled in SynCardia's four-phase certification program surpassed 100. There are currently 68 SynCardia Certified Centers worldwide, spanning 15 countries.

In June, SynCardia was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won "Company of the Year – Health Products and Services" and "Most Innovative Company of the Year – up to 100 Employees."

In May, the Freedom® portable driver was selected as the Bronze Winner in the Critical Care and Emergency Medicine category of the 2012 Medical Design Excellence Awards (MDEA) in Philadelphia.

CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,000 implants of the Total Artificial Heart, accounting for more than 270 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

SynCardia Wins Two Gold Stevies® at 2012 American Business Awards

On June 18, 2012, SynCardia was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won "Company of the Year – Health Products and Services" and "Most Innovative Company of the Year – up to 100 Employees." See the full list of SynCardia Awards & Recognition, which includes accolades from Forbes, Fast Company and more.


'/>"/>
SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiac Science Earns Top Marks for Cardiac Stress Test, Telemetry Monitor Systems
2. Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities
3. Multiple Sclerosis Association of Americas MRI Institute Marks 10 Years of Helping Individuals with Multiple Sclerosis Obtain MRIs
4. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
5. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
6. Allscripts Announces Second Quarter 2012 Results
7. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
8. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
9. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
10. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
11. diaDexus, Inc. Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/26/2016)... 26, 2016 TARE (Transarterial ... Cost Savings and Overall Decreased Use of ... an international specialist healthcare company, has today announced ... Annual Meeting of ISPOR (International Society for Pharmacoeconomics ... carcinoma (HCC) using yttrium-90 glass microspheres is associated ...
(Date:5/26/2016)... , May 26, 2016 ... has matured into an essential life science tool for ... development applications. BCC Research reveals in its new report ... second growth phase, one powered by a range of ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology:
(Date:5/31/2016)... PA (PRWEB) , ... May 31, 2016 , ... More ... Philadelphia, Hep B United Philadelphia, and the Prevent Cancer Foundation held an event on ... silent epidemic in the city of viral hepatitis, the leading cause of liver cancer. ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader in ... Networks Co., the leading provider of secure mobile remote access solution for Japan ... leading CACHATTO remote access solution. Splashtop for CACHATTO will be available as ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices ... But this approach has proven transformative, both for people who hear voices and for ... is used around the world, but it still lags in the United States. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... ... May 31, 2016 , ... CallTrackingMetrics's software ... campaigns, to monitor the performance of sales and support staff, and to efficiently ... The software allows customers to record, transcribe, route, document, and report on everything ...
Breaking Medicine News(10 mins):